There are 2867 resources available
1232P - CROSS protocol for esophageal cancer in India: Reality or pipe dream?
Presenter: Kumari Puja
Session: Poster session 16
1233P - Real world outcomes of FLOT versus CROSS for patients with oesophageal or gastro-oesophageal junction cancer
Presenter: Adel Shahnam
Session: Poster session 16
1234P - Neoadjuvant camrelizumab plus docetaxel and carboplatin in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective study
Presenter: Rui Wang
Session: Poster session 16
1235P - Analytical performance of PD-L1 IHC 28-8 pharmDx in gastric, gastroesophageal junction (GEJ), and esophageal carcinoma evaluated using combined positive score (CPS)
Presenter: Tabitha Chan
Session: Poster session 16
1236P - Comorbidities and their association with the overall survival in a large European cohort with gastroesophageal cancer
Presenter: Hannah Puhr
Session: Poster session 16
1237P - Phase I study to evaluate the safety, tolerability and preliminary efficacy of rivoceranib plus paclitaxel in advanced gastric or gastroesophageal junction (GEJ) cancer
Presenter: Min Hee Ryu
Session: Poster session 16
1238P - Effect of a standardized nutritional support program on nutritional status, body composition, morbidity and mortality in patients with advanced upper gastrointestinal (UGI) cancer before and after neo-adjuvant radio-chemotherapy followed by surgery
Presenter: Christian Fottner
Session: Poster session 16
1239P - Radiomics biomarkers are associated with survival in patients with oesophageal adenocarcinoma
Presenter: Lauren Aoude
Session: Poster session 16
1240P - Activation status of CD8+ T and Treg cells in the tumor microenvironment potentially predicts the clinical efficacy of nivolumab in advanced esophageal squamous cell carcinoma
Presenter: Hayato Mikuni
Session: Poster session 16
1241P - Phase Ib study of futibatinib plus pembrolizumab in patients with advanced or metastatic solid tumors: Tolerability results and antitumor activity in esophageal carcinoma
Presenter: Kei Muro
Session: Poster session 16